We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Glutaraldehyde Test Evaluated for Rapid Tuberculosis Diagnosis

By LabMedica International staff writers
Posted on 16 Nov 2017
Print article
Image: A digitally colorized scanning electron microscopic (SEM) image depicts a large group of orange-colored, rod-shaped Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB) in human beings (Photo courtesy of US National Institute of Allergy and Infectious Diseases).
Image: A digitally colorized scanning electron microscopic (SEM) image depicts a large group of orange-colored, rod-shaped Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB) in human beings (Photo courtesy of US National Institute of Allergy and Infectious Diseases).
Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and the primary method for controlling TB is the rapid and accurate identification of infected individuals.

Smear examination and culture of Mycobacterium tuberculosis bacilli have remained the gold standard, but the sensitivity of the direct smear examination of sputum, however, is low, while culture is time-consuming, labo¬rious and not always available. Immune response exploitation represents one of the main methods used for early TB diagnosis.

Microbiologists at the University Hospital Farhat Hached (Sousse, Tunisia) determined the diagnostic value of a glutaraldehyde test (GT) in pulmonary tuberculosis (PTB) and extra-pulmonary tuberculosis (EPTB) and to assess its performance compared with light-emitting diode fluorescence microscopy (LED-FM). This study included 272 specimens, 176 suspected PTB specimens and 96 suspected EPTB specimens. Of the 272 patients, 98 patients had TB infection confirmed by culture (64 PTB cases and 34 EPTB cases), and 174 patients had no TB infection. The gold standard technique (culture) was used as reference to verify the GT’s performance.

Sputum, extra-respiratory and blood samples for the GT were preferably collected on the same day. All specimens were subjected to smear examination, and each specimen was inoculated into Lowenstein-Jensen (LJ) and Coletsos culture media for up to eight weeks. Positive growth was confirmed by Ziehl-Neelsen staining, and mycobacterial isolates were identified using conventional biochemical techniques. The GT kit, ANDA-TB GA test case finding was used and a gelification time less than 10 minutes denotes a possible TB infection.

The team reported that the GT showed a high sensitivity (96.9%) and specificity (82.1%) for PTB with a good positive predictive value (PPV = 75.6%) and negative predictive value (NPV = 97.9%). For EPTB, the GT showed a sensitivity of 91.2% and a specificity of 77.4%, with PPV = 68.9% and NPV = 94.1%. LED-FM had lower sensitivities for PTB (65.6%) and EPTB (42.1%) and an excellent specificity of 100%, with PPV = 100% and NPV = 100%.

The authors concluded that the GT is rapid, easy, simple and cost-effective and does not require qualified personnel with a specific background or sophisticated equipment like molecular biology or mycobacterium-specific genotyping techniques. These qualities make the GT attractive for use in low- and high-income countries in addition to other conventional methods, particularly culture, which continues to be the gold standard. The study was published in the November 2017 issue of the journal Memórias do Instituto Oswaldo Cruz.

Related Links:
University Hospital Farhat Hached


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The breakthrough could result in a higher success rate using a simple oral swab test before IVF (Photo courtesy of Shutterstock)

POC Oral Swab Test to Increase Chances of Pregnancy in IVF

Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.